BBIO
BridgeBio Pharma, Inc.NASDAQStock$79.67-0.74 (-0.92%)Mkt Cap 15.6BP/E —Div Yield —Beta 0.98Vol 967.2KAvg Vol 2.3M
52W$48.87
$90.17
ETFs That Hold BBIO (BridgeBio Pharma, Inc.)
1M
-5.29%
3M
+16.39%
6M
+19.84%
YTD
+1.83%
1Y
+63.02%
3Y
+177.89%
5Y
+57.82%
ETFs That Hold BBIO
BridgeBio Pharma, Inc. is held by 113 ETFs. The largest position by market value is in VB (Vanguard Morningstar Small-Cap ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| AAUB | Alpha Architect US Equity 4 ETF | 0.01% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.18% |
| PWS | Pacer WealthShield ETF | 0.23% |
| SZNE | Pacer CFRA-Stovall Equal Weight Seasonal Rotation ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.11% |
| MFIG | Motley Fool Innovative Growth ETF | 0.41% |
| STXG | Strive 1000 Growth ETF | 0.03% |
| SSMG | Virtus Silvant Small/Mid Growth ETF | 1.19% |
| PCSG | Polen 5Perspectives Small-Mid Growth ETF | 0.88% |
| FFF | Founders 100 ETF | 0.33% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.19% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.13% |
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 0.24% |
| WDNA | WisdomTree BioRevolution Fund | 0.52% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.01% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.01% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.01% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.01% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold BBIO?
BridgeBio Pharma, Inc. (BBIO) is held by 113 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VB (Vanguard Morningstar Small-Cap ETF).
What is the largest ETF that holds BBIO?
By fund size, VB (Vanguard Morningstar Small-Cap ETF) with $183.40B in AUM holds 0.18% of its portfolio in BBIO, representing $324.4M in market value.
What percentage of HELX is BBIO?
BBIO makes up 3.66% of HELX (Franklin Genomic Advancements ETF), making it one of the largest positions in that fund.
Is BBIO in the S&P 500?
BBIO is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.